≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Myeloproliferative diseases (CML excluded)

DOID EFO Endpoint Browser PheWeb

MYELOPROF_NONCML

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not CML
519893

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D75.2

1 out of 7 registries used, show all original rules.

900

4. Check minimum number of events

None

900

5. Include endpoints

2861

6. Filter based on genotype QC (FinnGen only)

2861

Control definitions (FinnGen only)

Control conditions
not CML

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 2861 1515 1346
Unadjusted period prevalence (%) 0.55 0.52 0.59
Median age at first event (years) 63.63 62.23 65.21

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2298
Matched controls
22979
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
4522.6
323.0
390
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
323.0
309
*
L01XX05
ATC
hydroxycarbamide; oral
1989.7
323.0
1307
15
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
323.0
359
*
XW000
NOMESCO Finland
Bone marrow biopsy
24.9
323.0
710
405
D75.2
ICD-10 Finland
Essential thrombocytosis
341.6
323.0
605
24
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
110.3
323.0
1508
390
TPH00
NOMESCO Finland
Phlebotomy
358.4
323.0
361
12
D45
ICD-10 Finland
Polycythaemia vera
4555.2
323.0
1088
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
16384.0
323.0
1146
*
SPAT1074
SPAT
Venesection
214.6
260.7
266
14
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
33.6
208.5
276
93
L01XX35
ATC
anagrelide; oral
+∞
197.8
187
*
L03AB05
ATC
interferon alfa-2b; parenteral
180.4
191.0
198
12
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
1947.0
179.5
172
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
82.1
174.7
196
26
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
1275.4
125.2
121
*
L03AB04
ATC
interferon alfa-2a; parenteral
255.2
119.1
121
5
B99
ICPC
Blood/lymph/spleen disease other
50.5
106.7
129
27
174
Kela drug reimbursment
Ruxolitinib
+∞
97.6
93
*
M04AA01
ATC
allopurinol; systemic
3.3
89.9
541
1970
374
Kela drug reimbursment
Ruxolitinib
+∞
84.9
81
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
83.7
499
1794
D75.1
ICD-10 Finland
Secondary polycythaemia
34.7
79.0
103
31
L01XE18
ATC
[U] ruxolitinib; oral
+∞
71.2
68
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
69.0
339
1036
L01EJ01
ATC
ruxolitinib; oral
+∞
63.8
61
*
212
Kela drug reimbursment
Gout
7.6
55.9
135
186
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
36.8
47.7
61
17
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
29.9
47.6
64
22
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
414.8
41.3
41
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
16.8
40.0
64
39
D75.0
ICD-10 Finland
Familial erythrocytosis
53.2
39.6
47
9
WW500
NOMESCO Finland
Blood transfusion
3.8
37.6
167
461
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
8.3
37.6
85
106
B28
ICPC
Limited function/disability (B)
19.8
37.1
56
29
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
15.4
36.2
60
40
B74
ICPC
Malignant neoplasm blood other
37.3
34.7
44
12
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
33.2
1080
7828
L03AA04
ATC
NA
49.5
32.6
39
8
B04
ICPC
Blood symptom/complaint
18.5
31.8
49
27
B03XA02
ATC
darbepoetin alfa; parenteral
5.7
30.8
91
166
B01AB05
ATC
enoxaparin; parenteral
1.7
28.4
754
5078
B01AC14
ATC
[U] anagrelide; oral
+∞
26.1
25
*
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
50.6
25.3
30
6
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
15.4
25.1
41
27
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
+∞
24.0
23
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
7.6
22.6
53
71
TPH00
SPAT
NA
121.2
22.6
24
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
21.2
677
4711
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
20.2
20.4
30
15
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
58.0
19.9
23
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
16.5
19.6
31
19
B75
ICPC
Neoplasm blood benign/unspecified
105.9
19.6
21
*
L01AB01
ATC
busulfan; systemic
201.6
19.6
20
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
19.4
170
739
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
18.3
19.1
29
16
20899
ICD-8 Finland
Polycythaemia vera
+∞
18.8
18
*
B01AA03
ATC
warfarin; systemic
1.6
18.0
521
3510
R04.0
ICD-10 Finland
Epistaxis
2.1
17.3
198
972
D73.5
ICD-10 Finland
Infarction of spleen
21.0
17.3
25
12
I81
ICD-10 Finland
Portal vein thrombosis
10.8
16.9
32
30
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.1
16.6
64
158
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.7
16.1
70
192
R50.9
ICD-10 Finland
Fever, unspecified
1.8
15.7
304
1814
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
15.4
195
1002
C03CA01
ATC
furosemide; systemic
1.5
15.3
711
5324
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
10.1
14.9
29
29
PH_2
NOMESCO Finland
Other procedures on veins
+∞
14.6
14
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
14.0
259
1522
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
+∞
13.6
13
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
13.4
152
746
D69.1
ICD-10 Finland
Qualitative platelet defects
40.3
13.2
16
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
13.1
166
852
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
8.1
12.8
28
35
2387B
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[THROMBOCYTHAEMIA IDIOPATHICA]
+∞
12.5
12
*
S97
ICPC
Chronic ulcer skin
2.1
12.5
142
699
ZY010
NOMESCO Finland
Hospital outpatient
2.6
12.4
89
347
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
12.5
12.1
21
17
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.9
12.1
193
1081
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
12.0
441
3112
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
12.0
254
1555
B03XA01
ATC
erythropoietin; parenteral
5.1
12.0
37
74
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
11.4
217
1289
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
11.3
135
677
306
Kela drug reimbursment
Erythropoietin and darbepoetin
8.6
11.0
23
27
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
11.0
332
2235
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
6.0
10.9
29
49
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
10.9
127
631
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
15.5
10.8
17
11
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
60.3
10.6
12
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
10.6
225
1380
XW000
SPAT
NA
110.5
10.4
11
*
2387A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[MYELOFIBROSIS]
+∞
10.4
10
*
A05AA02
ATC
ursodeoxycholic acid; oral
4.2
10.3
38
92
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
10.3
249
1582
R71
ICD-10 Finland
Abnormality of red blood cells
13.2
10.2
17
13
K99
ICPC
Cardiovascular disease other
2.5
10.1
76
309
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.3
10.0
92
412
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.5
9.8
75
307
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
26.1
9.8
13
5
J01DB01
ATC
cefalexin; oral
1.4
9.8
1690
15412
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
9.8
239
1524
C07AB07
ATC
bisoprolol; oral
1.3
9.8
1052
8939
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
9.7
353
2474
J01MA12
ATC
levofloxacin; systemic
1.5
9.7
388
2779
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.8
9.7
154
860
127
Kela drug reimbursment
Transplant complication
3.9
9.5
37
95
D73.1
ICD-10 Finland
Hypersplenism
21.8
9.3
13
6
ZX120
NOMESCO Finland
Intravenous
1.7
9.1
196
1208
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
9.0
466
3502
D68.8
ICD-10 Finland
Other specified coagulation defects
4.4
9.0
31
71
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
36.8
9.0
11
*
SPAT1088
SPAT
Blood transfusion
6.1
8.9
23
38
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
3.1
8.7
45
146
C90.0
ICD-10 Finland
Multiple myeloma
3.5
8.6
38
109
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.7
8.6
55
204
A02BC02
ATC
pantoprazole; systemic
1.3
8.4
1359
12112
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
8.3
8
*
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
+∞
8.3
8
*
M10.9
ICD-10 Finland
Gout, unspecified
1.8
8.2
149
872
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
3.8
8.1
32
84
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
17.2
8.1
12
7
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
8.0
423
3186
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
8.0
219
1435
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.6
8.0
53
203
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
15.1
7.7
12
8
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
3.1
7.6
40
132
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
18.4
7.6
11
6
Z3231
NOMESCO Finland
Registered nurse
1.3
7.6
550
4363
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
11.9
7.6
13
11
D58.2
ICD-10 Finland
Other haemoglobinopathies
25.1
7.6
10
*
D47
ICD-10 Finland
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
80.3
7.4
8
*
WW200
NOMESCO Finland
Immunization
2.4
7.3
56
233
ZXE00
NOMESCO Finland
One hour or less
1.3
7.3
753
6280
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
10.9
7.3
13
12
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
7.1
500
3944
I82.0
ICD-10 Finland
Budd-Chiari syndrome
20.1
7.1
10
5
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
7.1
145
881
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
6.9
203
2874
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.0
6.9
85
437
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.8
6.9
103
569
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
5.0
6.8
20
40
L04AX02
ATC
thalidomide; oral
16.7
6.7
10
6
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.4
6.7
52
218
C03DA01
ATC
spironolactone; oral
1.5
6.7
238
1657
K93
ICPC
Pulmonary embolism
3.4
6.7
30
89
AA1AD
NOMESCO Finland
CT of head and brain
1.3
6.7
504
4015
H02AB06
ATC
prednisolone; systemic
1.3
6.7
929
8027
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.3
6.6
59
264
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
6.6
218
1495
M10.4
ICD-10 Finland
Other secondary gout
12.3
6.6
11
9
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
10.0
6.5
12
12
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.6
6.5
164
1058
A46
ICD-10 Finland
Erysipelas
1.4
6.5
287
2088
R60.0
ICD-10 Finland
Localized oedema
1.5
6.4
227
1583
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
8.2
6.3
13
16
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
3.2
6.3
30
94
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
11.0
6.3
11
10
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.8
6.3
94
520
L03AB01
ATC
interferon alfa natural; parenteral
+∞
6.3
6
*
R51.80
ICD-10 Finland
Headache
1.5
6.2
232
1632
V03AC03
ATC
deferasirox; oral
26.7
6.2
8
*
R89.8
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, other abnormal findings
26.7
6.2
8
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
6.2
180
1203
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
6.1
1274
11490
J96.1
ICD-10 Finland
Chronic respiratory failure
2.4
6.1
47
196
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
6.1
361
2771

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013115) Eosinophils [#/volume] in Blood
2325
12047
5.96
307.65
16.4
5.7
e9/l
0.2
0.2
5.18
2162
10467
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1874
2861
17.09
307.65
9.7
3.8
u/l
286.2
245.1
13.90
1820
2689
(3017181) Myelocytes/100 leukocytes in Blood
819
2004
5.32
307.65
10.3
3.8
%
1.3
0.8
3.87
378
590
(3023520) Reticulocytes [#/volume] in Blood
1057
2210
7.00
307.65
3.9
2.5
e9/l
79.2
69.1
12.56
789
1695
(3018010) Neutrophils/100 leukocytes in Blood
2230
11007
5.65
307.65
15.5
5.7
%
61.4
57.8
35.83
2156
10223
(42870588) Differential panel, method unspecified - Blood
1887
8103
4.90
307.65
15.5
5.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2258
11184
5.83
307.65
17.2
5.9
%
24.4
27.0
24.09
2191
10344
(3045142) Bone marrow Pathology biopsy report
620
253
31.01
307.65
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
477
209
27.19
307.65
1.1
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2299
11654
5.95
307.65
15.0
5.5
e9/l
0.1
0.0
72.68
2123
9974
(3042111) Morphology [Interpretation] in Bone marrow Narrative
680
402
21.88
307.65
1.4
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2250
10960
5.93
307.65
17.6
6.0
%
8.2
8.8
15.93
2185
10192
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
905
205
64.11
307.65
1.1
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2294
11599
5.93
307.65
14.9
5.5
e9/l
0.6
0.6
1.61
2118
9915
(3026493) Urate [Moles/volume] in Serum or Plasma
1664
6349
4.87
307.65
4.6
2.7
umol/l
1669.2
6135.5
7.32
1545
5423
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
814
381
29.46
307.65
1.3
1.2
u/l
26.1
46.8
1.29
672
331
(3006504) Eosinophils/100 leukocytes in Blood
2250
10915
5.97
307.65
16.6
5.7
%
2.7
2.8
4.64
2184
10107
(3027945) Reticulocytes/100 erythrocytes in Blood
1261
2982
6.77
307.65
4.0
2.5
%
1.9
1.8
2.42
1119
2627
(3022096) Basophils/100 leukocytes in Blood
2231
10633
5.99
307.65
16.5
5.8
%
1.1
0.7
81.85
2161
9862
(3019198) Lymphocytes [#/volume] in Blood
2305
11881
5.84
307.65
15.2
5.6
e9/l
2.0
1.9
0.20
2166
10346
(3002179) Metamyelocytes/100 leukocytes in Blood
756
1819
5.29
303.80
10.0
3.7
%
1.1
0.5
6.17
280
421
(3021440) Promyelocytes/100 leukocytes in Blood
760
1910
5.06
288.82
10.1
3.9
%
0.2
0.1
2.18
361
548
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1043
3375
4.29
285.80
2.8
2.6
%
22.4
22.3
0.12
919
2882
(3013650) Neutrophils [#/volume] in Blood by Automated count
2370
13641
5.30
280.70
21.4
8.7
e9/l
5.4
4.2
23.94
2213
11838
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1059
3609
4.07
267.41
2.6
2.5
g/l
2.4
2.3
10.70
1002
3335
(3025159) Blasts/100 leukocytes in Blood
703
1787
4.89
261.41
10.3
3.9
%
1.0
0.3
1.25
297
454
(3022948) Iron [Moles/volume] in Serum or Plasma
1097
3891
3.95
260.48
2.7
2.5
umol/l
13.2
12.6
1.47
1040
3601
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
358
640
6.25
195.08
2.6
2.4
g/l
3.3
3.6
4.82
340
605
(40760892) CBC W Ordered Manual Differential panel - Blood
1136
4830
3.24
192.75
12.6
4.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2076
12728
3.30
179.99
9.8
6.2
umol/l
12.3
11.8
0.98
2019
12048
(3004809) Band form neutrophils/100 leukocytes in Blood
262
423
6.72
157.16
9.0
3.3
%
1.6
1.4
0.61
198
323
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1663
9565
2.76
151.36
3.9
2.8
ug/l
149.4
142.5
0.22
1544
8720
(3021589) Normoblasts [#/volume] in Blood
1673
10296
2.50
122.46
21.1
9.8
e9/l
0.1
0.0
3.98
1491
8363
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
411
1227
3.74
117.26
1.8
1.8
g/l
1.1
1.5
18.96
352
1057
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
281
670
4.54
108.72
2.3
2.1
%
92.8
89.4
1.56
244
638
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1156
6404
2.35
101.72
2.6
2.2
mg/l
5.1
3.0
22.90
989
5415
(3017354) Segmented neutrophils/100 leukocytes in Blood
166
263
6.64
100.79
9.2
3.3
%
67.8
56.5
5.71
96
166
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2407
18545
2.88
95.88
15.5
7.6
u/l
84.8
79.4
5.60
2342
17413
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
217
466
4.96
95.17
5.5
3.4
%
62.3
57.6
4.43
217
466
(3008757) Leukocyte morphology finding [Identifier] in Blood
163
281
6.09
90.95
10.8
3.9
—
—
—
0
0
(4212803)
62
24
26.38
89.69
1.0
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1812
12548
2.21
87.58
8.0
6.8
mmol/l
1.2
1.2
0.21
1523
10525
(3000093) Morphology [Interpretation] in Blood Narrative
140
223
6.55
84.45
1.1
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
54
18
30.56
82.03
1.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
89
86
10.65
80.94
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
239
648
3.93
77.33
1.9
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
1217
7485
2.09
76.90
5.7
4.0
ph
7.4
7.4
3.76
248
1432
(40758558) Short blood count panel - Blood
1019
6046
2.06
69.23
14.1
6.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1625
11416
1.98
67.63
7.3
6.0
mmol/l
1.2
1.2
5.06
1490
10273
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
216
619
3.69
64.32
2.8
2.3
%
176.3
197.0
2.54
207
589
(3017732) Neutrophils [#/volume] in Blood
382
1547
2.70
62.98
5.2
3.2
e9/l
5.5
4.1
6.04
249
1165
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
206
599
3.63
59.96
3.4
2.8
mg/l
1.4
1.6
6.18
199
538
(3021960) Folate [Moles/volume] in Serum or Plasma
993
6122
1.95
58.33
1.8
1.6
nmol/l
20.3
20.5
0.18
878
5159
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1488
10470
1.88
58.13
2.4
2.1
pmol/l
91.3
94.1
1.50
912
5323
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
61
5
124.62
57.03
1.1
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
88
130
6.95
56.90
1.9
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1500
10854
1.80
50.89
6.1
4.7
g/l
35.5
35.0
2.54
1405
10061
(3048879) Bone marrow aspiration report
64
77
8.48
49.35
1.5
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
960
6151
1.84
48.05
5.5
3.9
%
83.3
87.8
5.81
909
5996
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
517
2696
2.12
47.13
4.9
2.6
umol/l
6.9
8.8
1.69
466
2354
(3020630) Protein [Mass/volume] in Serum or Plasma
446
2195
2.22
47.08
2.9
2.7
g/l
66.7
66.3
0.55
405
1995
(3036489) Thrombin time
233
848
2.90
46.61
2.7
1.9
s
22.6
21.6
0.65
206
755
(3013826) Glucose [Moles/volume] in Serum or Plasma
1841
14450
1.77
44.46
5.6
4.8
mmol/l
6.6
6.8
5.83
1773
13576
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
75
125
6.13
43.18
8.0
2.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
589
3322
1.97
42.87
4.8
5.6
mmol/l
1.1
1.0
1.92
549
3055
(3018677) aPTT in Platelet poor plasma by Coagulation assay
662
3888
1.91
42.71
2.7
2.0
s
32.1
29.9
11.32
624
3768
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
148
444
3.46
40.93
6.5
5.1
iu/ml
1298.1
700.2
0.39
16
65
(3004588) Protein electrophoresis panel - Serum or Plasma
378
1852
2.20
39.96
2.8
2.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
801
5105
1.79
39.27
2.1
1.7
mg/l
1.2
1.4
1.10
622
3940
(3012095) Magnesium [Moles/volume] in Serum or Plasma
670
4075
1.84
38.19
3.7
3.2
mmol/l
0.8
0.8
1.43
635
3788
(3013707) Erythrocyte sedimentation rate by Westergren method
2103
17476
1.77
38.17
5.2
4.2
mm/h
11.9
13.4
3.97
1968
16082
(3019309) Folate [Moles/volume] in Red Blood Cells
778
5058
1.74
34.90
1.9
1.8
nmol/l
1089.5
1176.0
1.89
587
3777
(3005719) IgG [Mass/volume] in Serum or Plasma
344
1709
2.15
34.89
2.9
2.8
g/l
10.4
10.6
0.40
312
1554
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
204
844
2.53
31.55
3.5
3.5
ratio
1.6
1.7
0.03
22
67
(3034860) Kappa light chains.free [Mass/volume] in Serum
208
872
2.49
31.28
3.5
3.5
mg/l
55.3
125.5
0.53
184
708
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
208
872
2.49
31.28
3.5
3.5
mg/l
37.4
71.2
1.29
185
708
(3028026) IgM [Mass/volume] in Serum or Plasma
282
1350
2.21
31.27
2.0
1.8
g/l
1.6
1.4
0.52
254
1227
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
113
348
3.34
29.99
2.9
2.6
u/ml
240.9
2390.0
—
7
27
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
64
132
4.94
29.31
1.7
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
64
132
4.94
29.31
1.7
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
228
1039
2.30
28.41
3.0
2.5
g/l
3.5
3.8
2.44
160
752
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
228
1040
2.30
28.34
3.0
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
228
1041
2.29
28.28
3.0
2.5
g/l
6.9
7.4
3.62
165
788
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
214
969
2.31
27.05
2.9
2.5
g/l
11.3
10.3
1.71
174
825
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
213
974
2.28
26.30
3.1
2.6
g/l
3.2
3.1
0.55
160
769
(3032080) INR in Blood by Coagulation assay
1339
10469
1.52
26.15
13.4
10.2
inr
1.4
1.3
2.04
432
2926
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
198
897
2.30
24.98
3.2
2.5
g/l
1.4
1.1
0.49
171
775
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
179
780
2.38
24.69
3.2
2.4
g/l
0.0
0.0
0.11
159
716
(3049242) von Willebrand panel - Platelet poor plasma
29
6
48.78
24.28
1.9
3.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
167
723
2.39
23.36
3.2
2.4
g/l
0.0
0.0
0.00
149
671
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
168
732
2.38
23.17
3.2
2.4
g/l
0.0
0.0
0.00
149
672
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
181
819
2.29
22.88
3.0
2.3
g/l
38.6
37.6
1.29
155
707
(3024471) HLA-A [Type]
36
57
6.38
21.82
1.0
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
358
2110
1.80
21.57
3.2
3.9
mmol/l
1.2
1.2
1.64
307
1829
(40760888) Immunoglobulin light chains.free panel - Serum
153
662
2.39
21.44
3.6
3.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
35
55
6.43
21.37
1.6
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
22
20
11.08
20.67
1.4
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1032
7943
1.47
20.11
3.3
3.1
ng/l
2254.5
1577.0
2.09
897
6848
(3037756) Immunofixation for Serum or Plasma
135
573
2.42
19.75
1.7
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
449
2885
1.66
19.71
1.3
1.3
titre
406.2
534.5
1.06
90
630
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2509
23058
1.72
19.66
26.8
15.8
mg/l
20.2
25.5
15.71
2172
18573
(3023368) Bacteria identified in Blood by Culture
938
7171
1.46
18.57
5.8
4.4
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
34
61
5.63
18.20
1.3
1.1
%
71.8
88.7
1.91
20
32
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
958
7381
1.45
18.10
4.3
3.1
u/l
32.7
38.7
1.34
917
6989
(3008536) Aspergillus sp Ab [Presence] in Serum
29
45
6.50
17.92
3.8
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
609
4309
1.53
17.54
2.2
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
98
381
2.63
17.26
1.2
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
308
1852
1.74
17.17
2.0
1.6
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
33
61
5.46
17.13
1.4
1.4
%
77.5
85.2
0.41
20
33
(40760410) HLA-B [Type] by High resolution
22
7
31.65
17.02
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
22
7
31.65
17.02
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
22
7
31.65
17.02
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
22
7
31.65
17.02
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
22
7
31.65
17.02
1.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
30
51
5.93
16.97
1.4
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
18
17
10.65
16.44
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
575
4070
1.52
16.41
1.5
1.5
g/l
2.4
2.6
0.99
357
2415
(3020779) Urea [Moles/volume] in Serum or Plasma
363
2310
1.65
16.37
5.7
7.1
mmol/l
9.7
10.4
1.03
341
2188
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
106
440
2.46
16.31
2.4
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
57
168
3.44
16.31
2.3
2.0
%
29.1
44.6
—
8
21
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
131
605
2.22
15.80
2.3
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
24
35
6.91
15.70
1.5
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
90
353
2.60
15.60
1.3
1.4
u/ml
162.3
119.9
0.28
13
69
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
44
113
3.94
15.38
1.8
2.6
%
81.1
96.0
1.84
39
107
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2366
21722
1.52
15.37
5.1
4.1
mmol/l
1.3
1.3
0.40
2224
19522
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
97
398
2.49
15.32
1.3
1.2
—
—
—
0
0
(4035726)
346
2217
1.64
15.14
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
116
519
2.29
15.11
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
334
2124
1.65
15.05
1.4
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
233
1342
1.80
15.02
1.3
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2080
18673
1.42
14.83
37.7
19.1
%
15.7
13.8
158.85
2064
18218
(3044640) Blood type and Crossmatch panel - Blood
975
7763
1.39
14.51
5.1
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
316
2001
1.65
14.46
4.4
4.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
151
763
2.03
14.45
3.8
3.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
124
584
2.17
14.27
2.5
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
363
2404
1.58
13.81
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
172
926
1.91
13.73
3.8
2.9
u/ml
0.4
0.4
0.04
100
528
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
76
294
2.63
13.58
1.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
86
354
2.47
13.52
1.2
1.2
u/ml
303.3
265.0
0.48
55
207
(3007853) Bacteria identified in Skin by Aerobe culture
413
2829
1.54
13.52
2.1
1.8
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
23
38
6.09
13.39
1.3
1.1
%
77.7
77.5
0.01
12
12
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
23
38
6.09
13.39
1.3
1.1
%
78.3
71.5
0.27
12
11
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
76
299
2.58
13.14
1.2
1.2
u/ml
2.1
3.5
0.56
30
94
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
45
132
3.45
13.03
3.6
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
45
132
3.45
13.03
3.6
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
45
132
3.45
13.03
3.6
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
45
132
3.45
13.03
3.6
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
74
291
2.58
12.81
1.1
1.2
u/ml
4.5
5.4
0.16
37
125
(3026782) Osmolality of Urine
660
5012
1.41
12.67
3.1
2.8
mosm/kgh2o
541.0
544.5
0.16
581
4280
(3011412) CD3 cells [#/volume] in Blood
58
202
2.91
12.66
3.7
2.1
e9/l
0.8
1.1
1.32
29
119
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
92
404
2.32
12.56
1.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
66
249
2.69
12.42
3.1
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
773
6060
1.38
12.21
3.8
3.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
37
101
3.70
11.93
4.1
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
37
101
3.70
11.93
4.1
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1041
8570
1.34
11.90
3.2
3.4
mmol/l
2.3
2.4
2.59
898
7376
(4306422)
73
296
2.50
11.89
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
55
194
2.87
11.75
2.6
2.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
79
335
2.40
11.69
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
37
103
3.63
11.61
4.1
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
53
185
2.90
11.55
1.3
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
119
600
2.03
11.51
1.2
1.2
titre
110.9
84.8
0.33
11
42
(3037692) Legionella sp identified in Specimen by Organism specific culture
32
81
3.98
11.46
1.3
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
190
1118
1.75
11.39
2.1
1.9
ug/l
1.4
2.3
0.92
168
976
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
43
134
3.24
11.36
4.1
2.1
e6/l
1476.4
561.5
0.49
34
113
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1632
14376
1.31
11.32
3.8
3.2
u/l
61.1
52.9
2.83
1544
13199
(3036481) Cortisol [Moles/volume] in Serum or Plasma
316
2119
1.55
11.31
2.1
2.2
nmol/l
402.0
372.6
1.48
292
1921
(36304419) Bacteria [Presence] in Urine
837
6724
1.35
11.12
3.5
3.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
47
157
3.03
11.07
2.2
2.0
%
71.4
71.8
0.05
42
146
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
62
241
2.61
11.04
1.2
1.2
u/l
50.2
57.1
0.50
39
170
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
41
127
3.26
10.95
4.4
2.1
e9/l
0.2
0.2
0.28
35
113
(3002582) Erythrocytes [#/volume] in Urine
929
7593
1.33
10.94
3.6
3.3
e6/l
61.3
80.6
0.38
726
5907
(21494890) Protein electrophoresis panel - 24 hour Urine
68
280
2.46
10.75
2.4
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
66
268
2.50
10.75
3.1
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1828
16416
1.31
10.72
4.8
4.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1334
11497
1.30
10.58
5.3
5.2
estimate
0.0
0.0
0.50
362
2172
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
58
224
2.62
10.47
3.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
58
224
2.62
10.47
3.1
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
58
224
2.62
10.47
3.1
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
45
152
2.99
10.42
2.3
2.1
%
16.3
13.7
0.34
15
56
(3019550) Sodium [Moles/volume] in Serum or Plasma
2549
24156
1.51
10.40
28.1
18.5
mmol/l
139.4
139.6
4.03
2509
23531
(3035350) Ketones [Presence] in Urine by Test strip
1331
11485
1.30
10.39
3.9
3.9
estimate
0.0
0.0
0.00
372
2148
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
44
147
3.02
10.38
3.8
2.0
e6/l
2791.7
707.4
0.44
21
64
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1304
11226
1.30
10.34
7.8
4.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
119
624
1.95
10.33
1.5
1.5
g/l
0.2
0.2
1.37
108
594
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
68
287
2.40
10.21
1.0
1.1
%
111.1
115.8
0.58
62
261
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
748
5972
1.34
10.20
5.0
2.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1344
11640
1.29
10.09
3.9
3.9
estimate
0.0
0.0
1.08
364
2109
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
78
352
2.25
10.06
1.1
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
853
6958
1.32
9.99
3.6
3.2
e6/l
0.5
0.5
0.11
654
5325
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
622
4842
1.36
9.98
3.4
3.1
mmol/l
2.4
2.5
2.38
537
4254
(3023103) Potassium [Moles/volume] in Serum or Plasma
2551
24213
1.49
9.97
29.7
18.7
mmol/l
4.0
4.0
7.63
2507
23552
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
121
647
1.91
9.92
1.4
1.5
g/l
1.1
1.2
1.42
111
615
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
39
125
3.15
9.88
1.1
1.1
u/l
125.5
86.3
1.59
27
93
(40765089) Chromosome analysis panel - Blood by G-banded
16
25
6.43
9.81
1.1
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
22
47
4.71
9.76
1.6
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
39
126
3.12
9.75
1.1
1.1
u/l
41.5
27.4
0.86
28
91
(3042936) Bacteria identified in Isolate by Culture
471
3520
1.40
9.65
2.1
2.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
26
65
4.03
9.50
1.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
249
1647
1.56
9.45
3.9
3.6
kpa
5.2
5.2
0.10
221
1511
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
238
1559
1.57
9.43
3.9
3.6
mmol/l
2.0
1.9
0.11
172
1150
(3019225) pH of Specimen
365
2616
1.45
9.42
5.1
4.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
153
898
1.74
9.29
2.3
2.2
ug/l
271.4
744.4
1.30
146
847
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
17
30
5.69
9.27
1.1
1.4
nmol/l
8.9
4.8
0.66
12
24
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2265
21125
1.35
9.25
5.4
4.9
mu/l
2.1
2.0
0.12
2114
19073
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
928
7722
1.30
9.25
2.1
2.2
u/l
136.7
224.8
4.32
866
7211
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
105
554
1.93
8.99
1.2
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
244
1625
1.55
8.99
4.0
3.6
ph
7.4
7.4
0.14
29
200
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
337
2401
1.46
8.96
2.1
2.1
g/l
0.2
0.2
0.58
302
2235
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
246
1643
1.54
8.95
1.7
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2385
22451
1.37
8.95
5.6
4.6
mmol/l
1.3
1.5
55.51
2249
20361
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2330
21854
1.36
8.94
26.0
14.9
ml/min/173m2
76.2
76.6
0.41
2047
18123
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
38
128
3.00
8.88
1.6
2.8
%
30.8
39.1
0.84
11
47
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1148
9855
1.28
8.85
2.5
2.2
nmol/l
78.5
78.9
0.18
1016
8669
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
34
108
3.17
8.77
1.6
2.5
u/ml
1576.9
1273.1
0.20
34
108
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2401
22644
1.38
8.75
5.6
4.6
mmol/l
4.2
4.6
77.79
2280
20684
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
206
1330
1.59
8.69
2.9
3.2
pmol/l
4.4
4.4
0.51
167
1156
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
25
65
3.87
8.68
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1132
9721
1.27
8.64
4.3
3.9
ng/l
47.9
102.7
0.64
886
7152
(3000850) Epithelial cells [#/volume] in Urine
667
5353
1.32
8.56
2.9
2.6
e6/l
4.8
5.4
0.64
599
4712
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
910
7618
1.29
8.50
2.8
2.6
u/l
53.2
58.1
3.86
829
7004
(46235355) HIV 1 and 2 tests - Meaningful Use set
382
2812
1.41
8.49
1.5
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1914
17528
1.28
8.42
4.3
4.0
pmol/l
15.1
15.0
1.63
1745
15726
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
50
202
2.50
8.31
1.2
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
402
2999
1.40
8.26
1.9
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
226
1512
1.54
8.16
6.2
7.0
mmol/l
24.7
25.0
0.39
226
1505
(40768443) Skin Pathology biopsy report
170
1064
1.64
8.15
1.2
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1025
8744
1.27
8.13
4.2
3.8
e6/l
117.3
118.4
0.01
763
6335
(3003181) Sodium [Moles/volume] in Urine
92
481
1.94
8.13
1.2
1.3
mmol/l
57.6
61.8
0.52
74
382
(3028433) Virus identified in Specimen by Culture
27
79
3.44
7.94
1.3
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
363
2679
1.41
7.93
3.8
3.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
401
3011
1.39
7.91
1.9
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
162
1010
1.64
7.90
2.0
1.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
106
596
1.81
7.51
1.9
2.0
mg/l
16.1
12.1
1.03
91
546
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
39
147
2.68
7.48
1.9
2.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
279
1986
1.45
7.44
3.1
2.8
ml/min/173m2
56.4
62.8
2.66
163
826
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
45
183
2.48
7.41
1.7
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
171
1098
1.59
7.41
2.9
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
368
2759
1.38
7.31
1.8
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2553
24463
1.41
7.24
22.9
10.9
u/l
25.2
25.7
0.96
2500
23499
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
68
335
2.05
7.13
1.4
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2435
23173
1.34
7.09
6.1
5.2
mmol/l
2.4
2.7
53.30
2307
21052
(4268621)
46
195
2.38
6.95
2.1
2.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
143
894
1.63
6.93
2.7
2.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
98
552
1.80
6.93
2.6
2.5
%
16.4
16.0
0.28
48
278
(3027315) Oxygen [Partial pressure] in Blood
104
597
1.77
6.90
4.8
4.8
kpa
8.2
8.4
0.72
104
590
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1017
8793
1.24
6.88
4.2
4.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
79
417
1.92
6.84
1.5
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
131
807
1.65
6.74
1.2
1.2
u/ml
0.2
0.8
—
7
67
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
59
282
2.12
6.72
1.5
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
433
3383
1.33
6.56
1.3
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
24
74
3.26
6.55
1.0
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
102
593
1.75
6.50
4.7
4.7
mmol/l
2.6
2.8
0.17
71
414
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
54
253
2.16
6.48
2.8
2.7
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
102
594
1.74
6.46
4.8
4.7
kpa
5.0
5.1
0.12
102
588
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
14
29
4.85
6.45
1.4
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
27
91
2.99
6.38
2.6
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
22
67
3.30
6.13
6.5
2.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
33
128
2.60
6.04
2.0
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
742
6286
1.24
5.87
4.3
4.3
estimate
0.0
0.0
0.88
356
2082
(3022217) INR in Platelet poor plasma by Coagulation assay
449
3580
1.30
5.86
32.9
26.9
inr
1.5
1.4
1.11
71
503
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
96
567
1.72
5.82
1.5
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
28
102
2.76
5.79
35.0
26.7
ug/l
118.4
115.6
0.10
28
85
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
148
976
1.54
5.77
1.7
1.8
u/l
40.4
38.5
0.50
122
846
(3021901) Oxygen saturation in Capillary blood
86
494
1.76
5.75
3.0
2.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2156
20352
1.24
5.69
32.5
16.9
%
39.2
39.1
0.15
1364
13522
(1616796) Gas panel - Central venous blood
98
586
1.70
5.69
3.7
3.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
297
2240
1.36
5.68
2.3
2.4
u/l
32.9
39.1
1.40
257
1922
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
18
51
3.55
5.60
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2280
21681
1.25
5.49
6.4
6.2
mmol/mol
38.4
40.5
23.18
2146
19836
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
123
788
1.59
5.46
1.4
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
600
5002
1.25
5.43
3.9
3.9
ng/l
648.9
566.8
0.07
485
4108
(3026008) Bacteria identified in Urine by Culture
902
7854
1.22
5.41
3.3
3.4
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
8
5
16.04
5.41
1.0
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
96
580
1.68
5.38
3.1
2.9
kpa
7.6
7.9
0.92
91
527
(3036603) Volume of Urine
37
161
2.32
5.35
1.9
1.4
ml
1440.3
1812.2
—
6
34
(3000991) Gas panel - Venous blood
283
2144
1.36
5.26
6.7
7.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
39
3.86
5.26
1.2
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
316
2435
1.33
5.25
3.4
3.4
kpa
5.7
5.8
0.90
307
2362
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
51
959
0.52
5.14
1.6
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
29
115
2.54
5.12
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
170
1187
1.46
5.07
4.4
3.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
64
350
1.85
5.07
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
60
324
1.87
4.95
1.4
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1716
15933
1.19
4.94
5.1
4.8
e6/l
3244.4
2105.6
0.16
20
251
(3002032) Base excess in Venous blood by calculation
313
2433
1.32
4.90
3.5
3.4
mmol/l
1.5
2.0
1.20
256
1946
(3011985) Renin [Units/volume] in Plasma
57
304
1.89
4.89
1.3
1.4
mu/l
75.7
51.5
0.26
47
270
(3014111) Lactate [Moles/volume] in Serum or Plasma
296
2285
1.33
4.87
5.8
6.6
mmol/l
1.5
1.4
0.52
288
2204
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
38
175
2.19
4.84
1.1
1.2
titre
140.0
120.3
—
5
32
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
146
1000
1.48
4.82
4.4
3.9
mmol/l
24.5
24.9
1.01
129
917
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
66
371
1.80
4.80
1.5
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
34
150
2.28
4.79
1.4
1.5
u/l
12.1
7.1
0.22
16
73
(3010421) pH of Blood
109
705
1.57
4.69
4.6
4.4
ph
7.4
7.4
0.23
102
587
(44806118)
52
273
1.92
4.69
1.8
1.5
—
—
—
0
0
(44790049)
52
273
1.92
4.69
1.8
1.5
—
—
—
0
0
(44790047)
52
273
1.92
4.69
1.8
1.5
—
—
—
0
0
(44790048)
52
273
1.92
4.69
1.8
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
262
1998
1.34
4.68
3.3
3.7
ng/l
87.7
93.9
0.57
223
1698
(3015235) Bicarbonate [Moles/volume] in Capillary blood
106
682
1.58
4.67
3.2
3.2
mmol/l
25.3
25.1
0.20
98
586
(3027801) Oxygen [Partial pressure] in Arterial blood
376
3018
1.28
4.64
6.9
7.0
kpa
11.9
12.0
0.16
361
2869
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
376
3018
1.28
4.64
6.9
7.1
kpa
5.0
5.1
1.47
362
2868
(3019060) Gas panel - Arterial blood
233
1754
1.36
4.54
5.1
4.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
339
2696
1.29
4.49
7.2
7.4
%
94.9
95.5
0.76
329
2590
(3001964) Herpes simplex virus Ag [Presence] in Specimen
19
65
2.94
4.44
1.5
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
30
4.01
4.43
1.4
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
62
352
1.78
4.40
1.6
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2355
22617
1.23
4.35
5.2
4.9
mmol/l
6.0
6.0
1.42
2147
20358
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
102
662
1.56
4.35
1.5
1.6
iu/ml
0.6
10.0
0.53
17
137
(3001686) Cold agglutinin [Titer] in Serum or Plasma
16
50
3.21
4.33
1.5
1.4
titre
—
127.3
—
0
9
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
16
50
3.21
4.33
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
14
40
3.51
4.33
1.4
1.8
e6/l
67.1
202.7
—
7
15
(3033799) Differential panel - Peritoneal fluid
21
78
2.70
4.25
2.3
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
98
1475
0.65
4.21
1.8
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
371
3013
1.27
4.16
7.0
7.0
mmol/l
1.1
1.1
0.05
291
2354
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
47
3.20
4.05
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
98
642
1.55
4.04
1.8
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
65
386
1.70
3.98
1.1
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
15
48
3.14
3.93
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
29
3.80
3.80
1.5
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
187
1401
1.36
3.80
7.6
9.0
mmol/l
24.5
24.4
0.04
181
1308
(3014576) Chloride [Moles/volume] in Serum or Plasma
396
3275
1.24
3.79
7.0
6.6
mmol/l
104.0
104.2
0.45
389
3193
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
44
3.19
3.77
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
476
4017
1.22
3.77
3.3
3.0
e6/l
1.7
2.4
1.57
244
2219
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
61
2.80
3.68
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
325
2639
1.26
3.66
1.2
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
51
291
1.77
3.62
1.2
1.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
35
3.44
3.61
1.8
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1783
16814
1.16
3.60
4.5
4.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
15
51
2.95
3.57
1.9
1.4
—
—
—
0
0
(3013512) EKG study
841
7504
1.17
3.56
4.6
4.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1055
9586
1.16
3.52
2.3
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
71
447
1.60
3.51
2.3
3.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
13
6.17
3.50
3.3
3.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
98
666
1.49
3.45
1.6
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
33
167
1.99
3.39
1.5
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
52
305
1.72
3.38
1.3
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
49
283
1.74
3.36
1.1
1.3
pmol/l
301.8
290.8
0.09
38
221
(3051651) Icteric interference index of Serum or Plasma
31
154
2.02
3.35
4.5
3.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
162
1213
1.36
3.33
3.8
3.6
mmol/l
23.9
24.2
0.43
154
1082
(3028707) Methadone [Presence] in Urine by Screen method
34
175
1.95
3.33
1.4
2.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
277
1.75
3.30
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
65
2.63
3.30
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
161
1214
1.35
3.18
1.4
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
26
124
2.11
3.14
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
81
541
1.51
3.13
2.4
2.9
umol/l
38.5
37.2
0.10
64
452
(36660697) Celiac disease serology panel - Serum
211
1658
1.29
3.12
1.2
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
144
1073
1.36
3.08
4.4
5.3
%
2.0
1.6
1.47
133
1003
(3028308) Erythrocytes [#/volume] in Pleural fluid
51
306
1.68
3.08
1.2
1.4
e6/l
130781.3
85344.3
0.29
32
182
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
41
699
0.58
3.07
1.5
1.7
mg/l
3.2
3.6
0.16
36
502
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
83
561
1.49
3.04
1.2
1.2
u/ml
1.8
4.0
—
5
54
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
84
571
1.49
3.00
1.2
1.2
u/ml
3.9
8.1
—
8
97
(44806071)
9
21
4.30
2.99
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
37
204
1.82
2.99
1.1
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
23
107
2.16
2.96
1.6
5.7
—
62.3
—
0
26
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
23
107
2.16
2.96
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
29
148
1.97
2.94
2.7
3.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
529
4615
1.18
2.90
1.3
1.2
u/ml
2.2
1.4
0.43
100
1173
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
76
2.38
2.89
2.2
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
45
266
1.70
2.89
1.4
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
24
115
2.10
2.88
2.1
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
24
115
2.10
2.88
2.1
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
52
320
1.64
2.87
1.8
1.6
g/l
0.8
0.8
0.01
39
240
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
13
5.39
2.87
1.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
52
321
1.63
2.84
2.8
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
58
368
1.59
2.84
2.5
2.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
35
193
1.82
2.84
1.6
1.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
25
123
2.04
2.81
2.6
3.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
30
158
1.91
2.80
1.9
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
51
315
1.63
2.79
2.8
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
493
4290
1.18
2.79
3.1
2.8
e6/l
0.8
1.2
1.77
260
2479
(40757373) Influenza virus identified in Isolate
16
65
2.47
2.79
1.4
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
59
378
1.57
2.78
1.2
1.5
g/l
30.9
32.0
0.30
52
343
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
19
84
2.27
2.77
2.2
2.0
e6/l
1335.8
23742.2
0.54
13
49
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
52
324
1.62
2.75
2.8
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
6
8.35
2.75
2.4
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
22
104
2.12
2.74
1.7
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
19
4.22
2.67
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
77
529
1.47
2.65
1.4
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
245
2004
1.24
2.64
3.0
2.9
kpa
4.5
4.5
0.00
239
1938
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
68
456
1.50
2.63
1.2
1.2
u/ml
1.3
4.8
—
5
34
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
99
714
1.40
2.63
1.8
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
26
134
1.95
2.60
1.2
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
296
2475
1.22
2.59
2.2
2.2
ug/g
184.6
157.9
0.36
237
1925
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
11
38
2.90
2.58
1.1
1.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
17
74
2.31
2.57
1.3
1.6
—
2024630.0
—
0
5
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
9
25
3.61
2.57
2.4
4.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
15
62
2.43
2.54
1.1
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
30
164
1.84
2.53
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
19
88
2.17
2.51
1.4
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
295
2475
1.21
2.50
7.9
7.8
g/l
119.4
121.0
0.54
285
2383
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
45
278
1.63
2.49
3.5
3.8
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
15
63
2.39
2.46
2.4
2.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
51
2.56
2.44
1.0
1.9
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
53
344
1.55
2.40
1.2
1.4
e6/l
1913.0
1805.0
0.07
37
250
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
25
131
1.92
2.40
2.1
2.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
44
275
1.61
2.34
1.3
1.3
mosm/kgh2o
272.4
276.9
0.65
37
206
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
49
315
1.57
2.33
2.9
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
162
1.80
2.31
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
49
317
1.56
2.27
2.9
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
23
3.48
2.27
1.6
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
35
208
1.69
2.26
1.5
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
279
2353
1.21
2.26
3.3
3.0
ng/l
229.1
220.8
0.12
256
2142
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
28
156
1.80
2.25
1.9
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
411
3589
1.17
2.24
1.2
1.2
u/ml
11.5
13.4
0.23
139
1336
(3004616) Nuclear Ab [Presence] in Serum
45
287
1.58
2.22
1.1
1.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
9
5.56
2.21
2.6
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
428
3756
1.16
2.19
1.3
1.3
iu/ml
27.8
38.2
1.14
137
1181
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
24
3.34
2.18
2.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
24
3.34
2.18
2.1
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
24
3.34
2.18
2.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1325
12490
1.11
2.17
2.7
2.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
49
321
1.54
2.16
2.9
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2576
25272
1.19
2.15
46.8
23.1
e9/l
401.5
245.4
316.86
2535
24559
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
45
290
1.56
2.14
1.2
1.2
nmol/l
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
24
130
1.85
2.12
1.3
1.3
nmol/l
1.4
1.2
0.36
15
101
(3007930) Methemoglobin/Hemoglobin.total in Blood
135
1059
1.29
2.11
4.7
5.4
%
0.9
0.9
0.57
124
990
(3024731) MCV [Entitic volume]
2576
25278
1.19
2.11
46.5
23.1
fl
94.0
91.4
25.70
2552
24842
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
72
513
1.41
2.11
1.4
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
2576
25279
1.19
2.10
46.4
23.0
pg
30.6
30.4
2.24
2552
24840
(3023487) Leukocytes [#/volume] in Peritoneal fluid
19
95
2.01
2.10
2.2
2.2
e6/l
560.4
776.9
0.42
13
74
(3026361) Erythrocytes [#/volume] in Blood
2576
25281
1.19
2.09
46.7
23.1
e12/l
4.4
4.4
0.26
2525
24480
(3010813) Leukocytes [#/volume] in Blood
2576
25286
1.19
2.06
46.8
23.2
e9/l
9.0
6.8
33.52
2527
24481
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
28
161
1.75
2.05
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
28
161
1.75
2.05
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
28
161
1.75
2.05
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
54
366
1.48
2.05
1.1
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2576
25287
1.19
2.05
47.0
23.3
g/l
131.7
134.1
9.37
2552
24856
(3023419) Bacteria identified in Sputum by Culture
52
350
1.49
2.04
2.4
2.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
15
69
2.18
2.04
1.1
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2428
23730
1.15
2.02
24.7
15.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
133
1.81
1.99
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
73
528
1.39
1.98
1.2
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
25
141
1.78
1.96
1.4
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
25
141
1.78
1.96
1.4
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
21
112
1.88
1.96
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
28
164
1.71
1.94
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
28
164
1.71
1.94
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
28
164
1.71
1.94
1.1
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
5
11
4.55
1.94
1.0
1.0
s
46.1
35.4
—
5
11
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
99
1.93
1.90
1.3
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
22
121
1.82
1.88
1.5
2.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
35
220
1.60
1.88
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
31
189
1.65
1.87
1.3
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
36
551
0.65
1.84
1.2
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
77
571
1.36
1.82
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
77
571
1.36
1.82
1.7
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
147
1191
1.25
1.80
4.1
3.8
%
45.6
48.2
0.61
142
1177
(4062490)
32
199
1.61
1.80
1.1
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
29
2.76
1.79
1.5
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
38
247
1.55
1.78
1.0
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
159
1302
1.23
1.78
3.2
3.2
mmol/l
24.6
25.3
1.49
151
1260
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
13
60
2.17
1.77
1.4
1.6
ug/l
0.5
0.3
—
8
32
(40768806) Pleura Pathology biopsy report
44
297
1.49
1.75
1.3
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
107
1354
0.78
1.74
1.4
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
89
682
1.31
1.71
1.2
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
32
202
1.59
1.71
1.4
1.2
nmol/l
339.7
359.4
0.21
27
172
(3024139) IgG subclass 3 [Mass/volume] in Serum
31
196
1.59
1.65
1.1
1.4
g/l
0.4
0.4
0.04
21
134
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
31
196
1.59
1.65
1.1
1.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
31
196
1.59
1.65
1.1
1.4
g/l
6.8
7.2
0.18
22
134
(3028192) IgG subclass 2 [Mass/volume] in Serum
31
196
1.59
1.65
1.1
1.4
g/l
2.6
2.9
0.48
21
134
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
25
2.80
1.65
2.3
2.8
u/field
0.4
0.8
—
7
25
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
182
1525
1.21
1.64
1.7
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
46
318
1.45
1.64
1.4
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
127
1.74
1.64
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
127
1.74
1.64
1.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
79
600
1.33
1.63
1.3
1.3
iu/l
26.7
31.4
0.76
72
510
(3017704) Immunofixation for Urine
26
158
1.65
1.62
2.6
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
58
420
1.39
1.61
1.4
1.3
u/l
12.9
10.3
0.89
51
335
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
682
6291
1.11
1.61
1.6
1.6
mmol/l
1.4
1.4
1.70
583
5208
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
24
143
1.68
1.61
3.5
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
89
689
1.30
1.61
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
75
568
1.33
1.58
2.3
2.2
g/l
131.6
128.0
0.40
60
411
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
18
99
1.82
1.57
2.1
2.6
—
—
—
0
0
(4198724)
11
50
2.20
1.57
1.4
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
351
3117
1.14
1.56
5.1
4.7
%
31.6
33.0
1.82
272
2015
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
129
1.71
1.56
1.2
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
57
2.11
1.55
1.8
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
47
331
1.43
1.54
2.5
2.5
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
8
33
2.43
1.53
1.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
38
257
1.49
1.53
1.8
2.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
89
695
1.29
1.52
1.2
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
21
2.86
1.50
1.7
2.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
182
0.49
1.50
1.4
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
24
148
1.63
1.44
1.5
1.5
g/l
1.0
1.0
0.03
24
148
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
16
3.13
1.44
1.2
1.0
%
24.0
20.5
—
5
16
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
16
3.13
1.44
1.2
1.0
%
9.0
7.5
—
5
16
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
16
3.13
1.44
1.2
1.0
%
39.9
38.4
—
5
16
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
16
3.13
1.44
1.4
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
73
561
1.31
1.42
1.2
1.1
u/ml
20.1
6.7
—
7
49
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
40
2.25
1.40
1.9
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
46
2.18
1.40
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
166
1404
1.19
1.40
9.1
9.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
39
271
1.45
1.39
1.2
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
23
2.61
1.36
1.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
23
2.61
1.36
1.3
2.1
—
—
—
0
0
(3035880) pH of Pleural fluid
25
159
1.58
1.34
1.2
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
150
0.47
1.31
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
173
0.52
1.29
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
173
0.52
1.29
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
173
0.52
1.29
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
173
0.52
1.29
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
87
695
1.26
1.28
4.3
4.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
158
1343
1.19
1.28
3.7
3.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
10
48
2.09
1.27
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
135
0.44
1.27
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
328
2945
1.13
1.26
1.4
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
16
92
1.74
1.25
1.4
1.5
%
4.8
3.1
0.22
16
76
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
35
245
1.43
1.23
1.4
1.7
—
1220.0
—
0
8
(3044242) Glucose [Moles/volume] in Arterial blood
22
139
1.59
1.23
1.5
2.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
37
2.17
1.21
1.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
145
0.48
1.19
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
145
0.48
1.19
1.6
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
26
2.31
1.18
7.0
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
48
358
1.35
1.18
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
349
3160
1.12
1.18
1.3
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
212
0.56
1.18
1.3
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
91
740
1.24
1.17
1.4
1.4
ug/g
293.7
277.7
0.36
56
433
(3040151) Glucose [Moles/volume] in Capillary blood
39
282
1.39
1.16
7.6
7.0
mmol/l
7.7
7.7
0.01
32
239
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
594
5531
1.09
1.16
1.6
1.7
pmol/l
23362930.6
24956262.5
0.02
458
4528
(3008152) Bicarbonate [Moles/volume] in Arterial blood
188
1640
1.16
1.13
8.6
6.8
mmol/l
24.1
24.6
0.74
177
1522
(3044007) Cell count panel - Peritoneal fluid
13
73
1.78
1.10
2.6
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
30
209
1.44
1.10
1.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
16
96
1.67
1.10
1.1
1.7
ug/l
2.5
5.2
—
9
74
(3051611) Lipemic interference index of Serum or Plasma
38
277
1.38
1.09
4.7
3.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
41
1.95
1.08
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1828
18749
0.93
1.08
41.7
20.6
g/l
325.7
331.8
55.87
1816
18584
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
158
1367
1.16
1.07
2.4
2.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
449
4852
0.91
1.05
2.8
3.1
ug/l
0.8
0.8
0.07
309
3337
(3027456) Digoxin [Moles/volume] in Serum or Plasma
79
642
1.24
1.05
3.5
3.2
nmol/l
0.8
0.8
0.30
59
500
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
13
75
1.74
1.02
1.0
1.3
ug/l
64.1
466.2
—
8
39
(1001926) Buprenorphine [Presence] in Urine by Screen method
40
299
1.34
1.00
1.4
1.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
28
390
0.72
0.98
1.5
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
37
275
1.35
0.97
1.6
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
50
1.80
0.96
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
229
2054
1.12
0.95
1.5
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
141
1.49
0.94
1.2
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
27
2.22
0.93
1.7
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
254
2296
1.12
0.92
1.6
1.8
%
1.5
1.5
0.15
215
1965
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
67
544
1.24
0.92
2.5
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
46
357
1.29
0.91
1.4
2.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
144
1257
1.15
0.90
1.3
1.3
u/ml
169.9
219.7
0.51
136
1153
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
15
94
1.60
0.90
2.0
2.0
umol/l
79.1
87.2
—
9
55
(3004119) Hemoglobin [Mass/volume] in Venous blood
182
1616
1.13
0.89
2.7
3.0
g/l
127.1
128.0
0.19
173
1573
(3019977) pH of Arterial blood
21
143
1.47
0.89
3.1
2.7
ph
7.4
7.4
—
8
46
(3003694) ABO and Rh group [Type] in Blood
635
6000
1.07
0.88
1.5
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
30
2.00
0.87
1.5
1.2
nmol/l
29.8
34.7
—
6
24
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
66
540
1.23
0.86
1.8
1.8
nmol/l
41.7
42.1
0.05
61
511
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
44
343
1.29
0.86
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
122
1057
1.16
0.86
5.8
4.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
120
1.50
0.85
1.2
1.8
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
13
80
1.63
0.84
1.2
1.2
g/l
38.1
38.6
—
7
40
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
20
137
1.46
0.84
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
57
1.76
0.83
2.8
2.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
588
5555
1.07
0.82
3.5
3.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
46
1.74
0.82
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
149
1317
1.14
0.81
1.2
1.2
iu/ml
99.7
141.0
0.87
52
475
(3038177) Helicobacter pylori Ab [Presence] in Serum
40
312
1.29
0.79
1.2
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
48
1.67
0.78
1.4
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
125
1094
1.15
0.78
1.5
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
110
954
1.16
0.78
2.4
3.2
u/ml
461.6
4418.0
0.75
94
814
(3021788) Differential panel - Synovial fluid
55
448
1.23
0.77
1.5
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
22
157
1.40
0.76
1.4
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
157
1.40
0.76
2.0
1.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
34
1.77
0.76
1.0
1.2
umol/24h
2.6
1.9
—
6
34
(3019150) Specific gravity of Urine by Refractometry
478
5072
0.93
0.74
4.3
4.4
kg/l
1.0
1.0
0.47
72
764
(3026480) Teichoate Ab [Titer] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
38
1.84
0.73
1.4
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
100
1.50
0.72
1.1
1.2
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
5
25
2.00
0.72
1.8
1.3
—
717.9
—
0
8
(1617658) Protocol used for examination of sentinel lymph nodes
14
207
0.67
0.72
1.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
39
1.80
0.72
1.4
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
95
821
1.16
0.72
1.6
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
10
60
1.67
0.72
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
45
554
0.81
0.70
1.4
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
169
1522
1.12
0.70
2.6
2.4
au/ml
26.4
25.1
—
9
65
(3023511) Choriogonadotropin [Units/volume] in Urine
22
160
1.38
0.70
1.1
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
259
2387
1.09
0.69
2.3
2.4
ug/l
5.1
7.1
2.03
200
2078
(3049717) Cytology report of Urine Cyto stain
118
1041
1.14
0.69
2.4
2.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
18
127
1.42
0.68
6.9
6.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
22
162
1.36
0.66
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
33
259
1.28
0.65
1.2
1.0
u/ml
3.5
2.2
—
9
91
(4211845)
8
127
0.63
0.64
2.6
4.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
50
601
0.83
0.64
1.7
1.7
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
25
190
1.32
0.62
4.8
4.7
u/ml
51.2
43.3
—
9
53
(3000764) Benzodiazepines [Presence] in Urine
47
389
1.21
0.60
1.4
1.9
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
647
6748
0.95
0.60
3.8
4.5
%
22.2
21.7
0.36
322
3423
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
47
390
1.21
0.59
1.4
1.9
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
64
1.56
0.58
1.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
19
140
1.36
0.58
1.3
1.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
17
123
1.38
0.57
1.8
2.5
ml
2131.2
1891.3
0.37
17
104
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
35
1.72
0.57
1.5
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
54
1.48
0.57
1.1
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
47
392
1.20
0.57
1.4
1.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
27
211
1.28
0.57
2.3
2.2
ml
671.1
622.2
0.28
16
137
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
133
1.36
0.55
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
22
168
1.31
0.55
1.3
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
38
1.58
0.54
1.0
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
90
796
1.13
0.54
5.8
3.9
mmol/l
4.0
3.9
1.09
85
737
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
60
1.50
0.54
1.0
1.3
ug/l
10.8
9.3
—
9
60
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
20
152
1.32
0.52
1.3
1.3
mmol/l
10.4
12.0
—
10
57
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
37
305
1.22
0.51
1.1
1.1
—
11.4
—
0
14
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
27
215
1.26
0.51
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
67
584
1.15
0.50
1.4
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
74
840
0.88
0.50
1.8
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
311
2934
1.07
0.50
1.4
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
27
335
0.80
0.49
3.1
4.8
umol/l
352.7
350.8
0.02
21
290
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
67
1.49
0.49
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
234
1.24
0.49
1.3
1.5
—
—
—
0
0
(4034850)
68
775
0.87
0.49
19.0
10.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
66
577
1.15
0.48
6.9
7.3
mmol/l
105.1
105.2
0.04
58
512
(3039000) Anion gap in Blood
66
577
1.15
0.48
6.9
7.3
mmol/l
12.0
11.2
1.07
58
512
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
155
0.71
0.48
1.4
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
99
890
1.12
0.48
2.9
3.0
g/l
0.3
0.3
0.27
42
326
(40761535) Cells panel - Urine sediment
198
2127
0.93
0.48
3.7
3.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
173
1600
1.09
0.47
2.8
2.2
nmol/l
12.7
12.8
0.04
154
1389
(3008898) HLA-B27 [Presence]
52
602
0.86
0.47
1.0
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
12
85
1.41
0.46
1.3
1.4
%
18.3
23.9
0.39
12
77
(3024869) Neuronal Ab [Presence] in Serum
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
117
0.68
0.45
2.6
4.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
18
138
1.31
0.45
7.4
14.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
50
1.40
0.45
6.6
8.1
—
—
—
0
0
(3016750) Collection duration of Urine
20
156
1.28
0.45
2.4
2.0
min
486.6
489.0
0.03
12
113
(3027944) Amphetamines [Presence] in Urine
45
386
1.17
0.43
1.5
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
157
1.28
0.43
1.6
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
32
1.56
0.42
1.4
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
57
1.40
0.42
5.9
7.9
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
57
1.40
0.42
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
144
1332
1.09
0.41
1.2
1.3
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
15
0.00
0.41
0.0
1.6
—
23.7
—
0
6
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
59
1.36
0.41
1.1
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
17
0.00
0.40
0.0
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
106
0.66
0.39
1.0
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
29
242
1.20
0.38
1.1
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
136
0.73
0.37
1.5
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
68
1.32
0.37
3.4
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
98
1.33
0.37
1.1
1.2
—
—
—
0
0
(4010399)
184
1728
1.07
0.37
1.4
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
22
179
1.23
0.37
1.1
1.1
—
4.4
—
0
8
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
69
1.31
0.37
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
69
1.31
0.37
1.3
1.1
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
5
37
1.35
0.37
1.4
1.3
%
42.0
73.8
—
5
32
(3006442) Creatine [Moles/volume] in Serum or Plasma
12
158
0.76
0.37
1.0
1.5
—
72.4
—
0
12
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
70
1.29
0.36
1.3
1.1
—
—
—
0
0
(4024509)
29
245
1.19
0.35
1.5
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
107
987
1.09
0.35
1.3
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
37
320
1.16
0.34
1.4
1.9
u/l
15413.8
2119.4
—
8
127
(3002619) Bacteria identified in Specimen by Culture
6
44
1.36
0.34
1.8
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
74
671
1.11
0.34
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
292
2792
1.05
0.33
2.9
4.0
ug/l
11.8
19.0
0.39
217
2303
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
28
328
0.85
0.32
1.2
1.5
—
—
—
0
0
(4027681)
14
110
1.27
0.31
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
208
0.82
0.31
1.1
1.7
%
12.1
11.2
0.33
17
208
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
308
3206
0.96
0.31
8.2
7.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
99
0.71
0.30
1.6
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
30
259
1.16
0.29
1.4
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
30
259
1.16
0.29
1.4
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
106
0.75
0.29
1.3
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
223
1.17
0.28
1.2
1.5
%
20.8
28.8
0.61
13
138
(3034274) Bile acid [Moles/volume] in Serum --fasting
18
149
1.21
0.27
1.7
1.8
umol/l
4.8
11.4
0.87
12
95
(3045414) Leukocytes [Presence] in Urine
118
1107
1.07
0.27
2.1
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
52
470
1.11
0.27
1.1
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
56
509
1.10
0.27
1.3
1.4
e6/l
1154.4
1469.2
0.11
46
411
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
56
509
1.10
0.27
1.2
1.4
e6/l
34.9
30.2
0.07
43
389
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
66
1.21
0.26
2.0
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
171
1627
1.05
0.26
3.3
3.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
74
0.68
0.26
1.2
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
9
72
1.25
0.25
1.6
1.2
%
94.7
108.6
—
9
62
(3023410) Appearance of Cerebral spinal fluid
27
235
1.15
0.25
1.1
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
771
7859
0.97
0.25
3.0
3.2
mmol/l
7.1
7.2
0.46
636
6518
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
76
1.18
0.24
1.4
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
76
1.18
0.24
1.4
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
87
1.27
0.24
1.2
2.0
ug/l
26.4
109.2
0.44
11
77
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
77
1.17
0.24
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
48
437
1.10
0.23
1.2
1.2
miu/ml
197.8
219.3
0.12
16
174
(3044927) Protein electrophoresis panel - Urine
33
294
1.12
0.23
1.5
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
92
0.76
0.22
1.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
153
1.18
0.22
1.9
1.3
u/ml
0.4
1.4
0.76
13
75
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
33
368
0.90
0.22
1.1
1.1
iu/ml
74.0
86.4
—
6
75
(4094501)
60
648
0.92
0.22
1.1
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
6.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
10
0.00
0.21
0.0
1.1
—
7.7
—
0
10
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3022475) Manganese [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.4
—
0
5
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
80
1.25
0.20
3.9
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
80
1.25
0.20
3.9
2.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
6
49
1.22
0.20
1.2
1.1
—
5.5
—
0
7
(3014051) Protein [Presence] in Urine by Test strip
64
597
1.07
0.19
2.5
2.2
—
—
—
0
0
(1002224) Polysomnography panel
81
764
1.06
0.18
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
109
1.19
0.18
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
59
1.19
0.18
1.7
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
37
340
1.09
0.16
2.0
2.3
mg/l
14.8
22.7
—
5
78
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
67
632
1.06
0.16
1.2
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
33
302
1.09
0.16
1.3
1.5
%
70.5
62.0
0.60
18
191
(3020682) Albumin/Creatinine [Ratio] in Urine
794
8044
0.98
0.16
3.8
4.0
mg/mmol
13.2
8.5
1.25
477
5045
(4015189)
8
72
1.11
0.16
3.0
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
55
584
0.94
0.14
2.1
1.8
—
—
—
0
0
(44806420)
7
88
0.79
0.14
2.1
2.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
15
131
1.15
0.14
1.7
1.4
pmol/l
44.5
70.4
—
9
44
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
60
567
1.06
0.14
2.1
3.3
u/ml
52.6
812.6
1.01
50
522
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
141
1.14
0.14
1.4
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
50
531
0.94
0.13
1.3
1.9
iu/l
2.7
4.7
2.06
17
179
(3047181) Lactate [Moles/volume] in Blood
85
813
1.05
0.13
6.7
6.3
mmol/l
1.5
1.3
0.43
75
709
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
232
0.90
0.13
1.1
1.0
u/ml
0.6
3.9
3.57
13
105
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
851
8422
1.01
0.13
4.5
5.2
ug/l
2.4
3.6
1.47
746
7488
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
55
580
0.95
0.12
1.6
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
38
406
0.94
0.12
1.5
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
734
7262
1.01
0.12
3.9
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
119
1153
1.03
0.11
1.7
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
178
0.90
0.11
1.1
1.0
u/ml
1.9
2.3
—
7
62
(3012516) Albumin [Mass/volume] in Urine
755
7626
0.99
0.11
3.2
3.3
mg/l
1334.1
297.8
2.62
460
4819
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
24
221
1.09
0.11
2.0
2.1
u/field
3.5
2.1
0.47
12
82
(3013139) Helicobacter pylori Ag [Presence] in Stool
146
1499
0.97
0.10
1.2
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
22
203
1.08
0.09
1.0
1.0
u/ml
5.1
1.8
—
5
46
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
16
145
1.10
0.09
2.0
2.1
ug/min
19.4
180.7
—
5
34
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
131
1278
1.03
0.09
1.8
1.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
196
0.92
0.09
1.5
1.5
nmol/l
0.2
0.3
0.24
12
150
(3015076) Soybean IgE Ab [Units/volume] in Serum
6
56
1.07
0.08
1.0
1.1
u/ml
—
0.7
—
0
6
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
136
1.10
0.08
1.8
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
62
0.81
0.08
1.2
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
62
0.81
0.08
3.4
3.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
67
1.04
0.08
1.3
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
18
166
1.08
0.07
1.3
1.4
promille
1.3
1.1
0.17
11
127
(44813793)
15
137
1.10
0.07
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
459
0.96
0.07
2.0
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
77
1.04
0.07
1.0
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
84
0.83
0.07
1.3
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
58
561
1.03
0.06
4.4
3.7
mg/l
30.3
27.1
0.26
35
353
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
138
1.09
0.06
1.8
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
9
104
0.86
0.06
1.2
1.3
umol/l
12.7
23.3
—
9
99
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
99
1011
0.98
0.06
1.1
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
59
607
0.97
0.05
1.6
1.6
e6/l
12033.5
14296.0
0.26
44
429
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
161
0.93
0.05
1.1
1.0
u/ml
3.7
2.9
—
7
60
(4281824)
24
252
0.95
0.05
1.2
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
179
1.06
0.05
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
31
322
0.96
0.04
1.8
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
227
2291
0.99
0.04
1.6
1.6
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
10
92
1.09
0.03
1.2
1.4
mmol/l
3.2
3.2
—
10
82
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
128
0.94
0.02
1.1
1.1
u/l
0.9
1.2
—
6
64
(4146454)
30
291
1.03
0.02
3.3
2.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
18
172
1.05
0.02
1.9
2.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
42
411
1.02
0.02
1.2
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
23
238
0.97
0.02
1.3
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
20
207
0.97
0.01
1.2
1.4
u/l
24.0
29.3
0.43
14
168
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
49
497
0.99
0.01
1.3
1.8
nmol/l
0.8
0.8
0.01
41
408
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
94
1.06
0.01
3.0
2.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
11
116
0.95
0.00
1.2
1.4
—
1.4
—
0
7
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
50
494
1.01
0.00
1.4
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
115
0.96
0.00
2.3
1.2
nmol/l
218.5
136.7
1.62
11
115
(3025577) Chromium [Mass/volume] in Blood
17
165
1.03
0.00
1.8
2.1
ug/l
2.2
2.0
0.16
17
143
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
26
265
0.98
0.00
1.1
1.1
u/ml
0.1
1.7
—
9
108
(3026470) Cobalt [Mass/volume] in Blood
17
169
1.01
0.00
1.9
2.0
ug/l
4.1
3.2
0.24
17
150
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
221
1.00
0.00
2.0
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
64
635
1.01
0.00
2.7
2.3
ug/min
163.7
102.0
0.36
36
386
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
104
0.96
0.00
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
226
1.02
0.00
1.0
1.0
u/ml
0.1
1.3
—
9
90
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
132
0.98
0.00
1.1
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
56
556
1.01
0.00
1.7
2.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
17
173
0.98
0.00
1.1
1.4
—
—
—
0
0
(4133840)
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
55
0.91
0.00
1.8
1.5
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1745.2
—
0
5
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
64
0.94
0.00
1.2
1.5
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
2.4
—
0
7
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
2984.0
—
0
5
(3015183) Erythrocyte sedimentation rate
8
86
0.93
0.00
1.1
1.3
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
2.7
—
0
9
(3042301) Urate [Moles/volume] in Synovial fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
211.2
—
0
5
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1270.0
—
0
5
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
49
1.02
0.00
10.4
2.9
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
54
0.93
0.00
4.6
4.7
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
9
0.00
0.00
0.0
5.9
—
13.5
—
0
9
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
1.3
—
0
8
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
7
74
0.95
0.00
1.6
1.3
%
26.9
25.2
—
7
59
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
68
0.88
0.00
1.0
1.1
miu/ml
2113.7
1618.1
—
6
68
(3005570) Glucose [Moles/volume] in Urine
27
270
1.00
0.00
2.2
2.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: MYELOPROF_NONCML – Myeloproliferative diseases (CML excluded)

GWS hits: 22

This endpoint is excluded (different definition than used in FinnGen).